Versatile covalent organic frameworks for cancer immunotherapy.
Cancer immunotherapy has produced substantial clinical benefit, yet its efficacy remains limited in patients with immunologically "cold" tumors, which are characterized by poor T-cell infiltration and a suppressive tumor microenvironment (TME). Strategies for converting cold tumors into immunologically "hot" phenotypes...